Literature DB >> 14996346

Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells.

M-C Liu1, M Yu, N-L Zhang, W-B Gong, Y Wang, W-H Piao, Q-H Wang, G-Q Wang.   

Abstract

The 2.2.15 cells-derived from HepG2 cells transfected with a plasmid containing hepatitis B virus (HBV) DNA secrete surface antigen (HBsAg) particles, nucleocapsids and virions (Proc Natl Acad Sci U S A 1987; 84: 1005-1009). The latter elicit acute hepatitis in chimpanzees (Proc Natl Acad Sci U S A 1987; 84: 4641-4644). We studied the presence of intracellular and extracellular HBV covalently closed circular (ccc) DNA in this culture system by polymerase chain reaction (PCR), kinetically analysed HBsAg and hepatitis B e antigen (HBeAg) released in the culture media by quantitative enzyme-linked immunosorbent assay and quantitated by real-time PCR but HBV DNA from intracellular and extracellular HBV-DNA. HBV cccDNA was found both intracellularly and extracellularly. A significant correlation was seen between the extracellular HBV DNA levels and virus antigens (r = 0.833; P = 0.01 and r = 0.939; P < 0.01 for HBsAg and HBeAg, respectively), whereas there was no statistical correlation between intracellular HBV DNA levels and virus antigen levels (r = 0.024; P = 0.955 and r = 0.177; P = 0.625 for HBsAg and HBeAg, respectively). These data would be valuable in studies of the HBV life cycle and of potential anti-viral agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996346     DOI: 10.1046/j.1365-2893.2003.00485.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata.

Authors:  Rui Wang; Zhen-Lan Du; Wen-Jun Duan; Xin Zhang; Fan-Lin Zeng; Xin-Xiang Wan
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.

Authors:  Hong Shi; Lu Lu; Ning-Ping Zhang; Shun-Cai Zhang; Xi-Zhong Shen
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

3.  Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease.

Authors:  Edward M Kennedy; Leda C Bassit; Henrik Mueller; Anand V R Kornepati; Hal P Bogerd; Ting Nie; Payel Chatterjee; Hassan Javanbakht; Raymond F Schinazi; Bryan R Cullen
Journal:  Virology       Date:  2014-12-29       Impact factor: 3.616

4.  A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.

Authors:  Anne Marie Dougherty; Haitao Guo; Gael Westby; Yuanjie Liu; Ender Simsek; Ju-Tao Guo; Anand Mehta; Pamela Norton; Baohua Gu; Timothy Block; Andrea Cuconati
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

5.  A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus.

Authors:  S Kiruthika; Ruchika Bhat; Rozaleen Dash; Anurag S Rathore; Perumal Vivekanandan; B Jayaram
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

6.  Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application.

Authors:  Sanae Hayashi; Masanori Isogawa; Keigo Kawashima; Kyoko Ito; Natthaya Chuaypen; Yuji Morine; Mitsuo Shimada; Nobuyo Higashi-Kuwata; Takehisa Watanabe; Pisit Tangkijvanich; Hiroaki Mitsuya; Yasuhito Tanaka
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.